Novo Nordisk’s TBL Explorer

Novo Nordisk’s Triple Bottom Line Explorer gives you an thorough understanding of the company’s approach to sustainability. The app introduces you to Novo Nordisk’s Triple Bottom Line (TBL) business principle and the initiatives and programmes that drive the company’s financial, social and environmental responsibility. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in todays business environment, recognised for its consistently high sustainability performance. For more information, please visit www.novonordisk.com/sustainability

This is the first version of Triple Bottom Line Explorer and we welcome your feed-back. Does it meet your information needs? Is it comprehensible? Is it user-friendly? You can let us know by sending an email to [email protected]

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 34,700 employees in 75 countries, and markets its products in more than 180 countries.